温阳复元方通过内外源铁死亡途径改善脑缺血再灌注损伤的效应机制研究OA
Study on the effect mechanism of Wenyang Fuyuan Prescription(温阳复元方)in ameliorating cerebral ischemia-reperfusion injury through endogenous and exogenous ferroptosis pathways
目的 探讨温阳复元方调控内外源途径相关蛋白表达抑制铁死亡,发挥其对脑缺血再灌注损伤(CIRI)模型大鼠脑保护的作用机制.方法 将36只健康雄性SD大鼠随机分为假手术组、模型组、Ferrostatin-1组、温阳复元方低、中、高剂量组,每组6只.除假手术组外,其余各组均制备CIRI模型,采用神经功能缺损评分对大鼠进行评定,TTC染色法评定大鼠造模是否成功,HE染色和尼氏染色比较各组大鼠脑组织损伤情况,免疫荧光法检测脑组织中ACSL4、NCOA4蛋白表达,qRT-PCR检测ACSL4、LPCAT3、NCOA4、FTH1的相对mRNA表达量,Western blot法检测ACSL4、LPCAT3、NCOA4、FTH1、GPX4相对蛋白表达量.结果 比较于假手术组,模型组大鼠脑组织出现大面积白色梗死灶,神经功能缺损评分显著上升(P<0.05),梗死侧脑细胞排列松散、胞质溶解、胞核碎裂,尼氏小体严重缺失,脑组织ACSL4、LPCAT3、NCOA4的蛋白及mRNA相对表达量升高(P<0.05),FTH1、GPX4蛋白及mRNA表达下降(P<0.05);与模型组比较,Ferrostatin-1组和温阳复元方中剂量组神经功能缺损评分显著下降(P<0.05),脑组织损伤程度减轻,神经元存活数量提高;中剂量组ACSL4、LPCAT3、NCOA4蛋白及mRNA表达明显降低(P<0.05),FTH1、GPX4蛋白及mRNA表达明显升高(P<0.05).结论 温阳复元方可改善CIRI大鼠神经功能与脑组织病理损伤,其机制可能与调节ACSL4-LPCAT3与NCOA4-FTH1通路相关蛋白抑制铁死亡有关.
Objective To investigate the mechanism of Wenyang Fuyuan Prescription(温阳复元方,WYFYP)by exploring its regula-tion of proteins related to endogenous and exogenous pathways to inhibit ferroptosis and exert its cerebral protective effects in a rat model of cerebral ischemia-reperfusion injury(CIRI).Methods Thirty-six healthy male SD rats were randomly divided into the sham-operated group,model group,Ferrostatin-1 group,and low-/medium-/high-dose WYFYP groups,with 6 rats in each group.Except for the sham-operated group,CIRI models were established in all other groups.Neurological deficit scores were assessed,and TTC staining was used to confirm the success of the rat modeling.HE staining and Nissl staining were used to compare brain tissue damage across groups,while immunofluorescence(IF)was employed to detect the protein expression of ACSL4 and NCOA4 in brain tissues.qRT-PCR was used to measure the relative mRNA expression levels of ACSL4,LPCAT3,NCOA4,and FTH1.Western blot(WB)was used to detect the relative protein expression levels of ACSL4,LPCAT3,NCOA4,FTH1,and GPX4.Results Compared with the sham-operated group,the model group showed large areas of white infarct foci(P<0.05),a significant increase in neurological deficit scores(P<0.05),loosely arranged brain cells,dissolved cytoplasm,fragmented nuclei,and severe loss of Nissl bodies on the infarcted side.The protein and mRNA expression contents of ACSL4,LPCAT3,and NCOA4 in the brain tissue were increased(P<0.05),while the pro-tein and mRNA expression of FTH1 and GPX4 were decreased(P<0.05).Compared with the model group,the Ferrostatin-1 group and the medium-dose WYFYP group showed a significant decrease in neurological deficit scores(P<0.05),reduced degree of brain tissue damage,and an increased number of surviving neurons.The medium-dose group also showed significantly decreased protein and mRNA expression of ACSL4,LPCAT3,and NCOA4(P<0.05),and significantly increased protein and mRNA expression of FTH1 and GPX4(P<0.05).Conclusion WYFYP improves neurological function and brain pathological brain tissue damage in CIRI rats,and its mecha-nism may be related to the inhibition of ferroptosis by regulating proteins associated with the ACSL4-LPCAT3 and NCOA4-FTH1 path-ways.
伍叙州;张鼎;周珂青;孙春英;陈灿荣;秦红玲;胡跃强
广西中医药大学研究生院,广西 南宁 530001广西中医药大学研究生院,广西 南宁 530001广西中医药大学研究生院,广西 南宁 530001广西中医药大学研究生院,广西 南宁 530001广西中医药大学研究生院,广西 南宁 530001广西中医药大学第一附属医院,广西 南宁 530023广西中医药大学第一附属医院,广西 南宁 530023
医药卫生
温阳复元方铁死亡铁自噬脂质过氧化ACSL4-LPCAT3通路NCOA4-FTH1通路脑缺血性再灌注损伤
Wenyang Fuyuan Prescription(温阳复元方)FerroptosisFerritinophagyLipid peroxidationACSL4-LPCAT3 pathwayNCOA4-FTH1 pathwayCerebral ischemia-reperfusion injury
《时珍国医国药》 2026 (15)
2801-2807,7
国家自然科学基金(82260904)国家中医药管理局高水平重点学科-中医内科学(ZYYZDXK-2023166)广西中医药大学"桂派杏林拔尖人才"计划(04B2300807,04B2300907)广西中医药大学"歧黄工程"高层次人才团队(202410)广西中医药重点学科建设项目(GZXK-Z-20-13)广西中医脑病临床研究中心项目(桂科AD20238028)广西(青年)岐黄学者培养项目(2025008-05-01)国家中医优势专科建设-脑病科项目(2025013-07-02)
评论